These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
For the quarterly period ended March 31, 2012
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
For the transition period from ____________ to __________
|
|
|
Delaware
|
01-0616867
|
|
(State of Incorporation)
|
(IRS Employer Identification No.)
|
|
1717 Doolittle Drive
|
94577
|
|
San Leandro, CA 94577
|
(Zip Code)
|
|
(Address of Principal Executive Offices)
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
(Do not check if a smaller reporting company)
|
|||
|
Page No.
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements (unaudited)
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011
|
3
|
|
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2012 and 2011
|
4
|
|
Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2012 and 2011
|
5
|
|
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2012 and 2011
|
6
|
|
Notes to Condensed Consolidated Financial Statements
|
7
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
17
|
|
Item 3. Quantitative and Qualitative Disclosures about Market Risk
|
23
|
|
Item 4. Controls and Procedures
|
24
|
|
PART II. OTHER INFORMATION
|
24
|
|
Item 1. Legal Proceedings
|
24
|
|
Item 1A. Risk Factors
|
25
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
34
|
|
Item 6. Exhibits
|
35
|
|
Signatures
|
36
|
|
|
March 31,
2012
|
December 31,
2011
|
||||||
|
ASSETS
|
||||||||
| Current assets: | ||||||||
|
Cash and cash equivalents
|
$ | 15,762 | $ | 18,507 | ||||
|
Restricted cash
|
6,161 | 5,687 | ||||||
|
Short-term investments
|
12,548 | 11,706 | ||||||
|
Accounts receivable, net of allowance for doubtful accounts of $187 and $248 at March 31, 2012 and December 31, 2011, respectively
|
6,316 | 6,498 | ||||||
|
Unbilled receivables
|
929 | 1,059 | ||||||
|
Inventories
|
8,350 | 7,824 | ||||||
|
Deferred tax assets, net
|
460 | 460 | ||||||
|
Prepaid expenses and other current assets
|
4,359 | 4,929 | ||||||
|
Total current assets
|
54,885 | 56,670 | ||||||
|
Restricted cash, non-current
|
5,323 | 5,232 | ||||||
|
Long-term investments
|
6,806 | 11,198 | ||||||
|
Land and building held for sale
|
1,650 | 1,660 | ||||||
|
Property and equipment, net
|
16,123 | 16,170 | ||||||
|
Goodwill
|
12,790 | 12,790 | ||||||
|
Other intangible assets, net
|
6,729 | 6,991 | ||||||
|
Other assets, non-current
|
2 | 2 | ||||||
|
Total assets
|
$ | 104,308 | $ | 110,713 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 1,438 | $ | 1,506 | ||||
|
Accrued expenses and other current liabilities
|
4,185 | 6,474 | ||||||
|
Income taxes payable
|
29 | 21 | ||||||
|
Accrued warranty reserve
|
864 | 852 | ||||||
|
Deferred revenue
|
1,499 | 859 | ||||||
|
Current portion of long-term debt
|
53 | 85 | ||||||
|
Current portion of capital lease obligations
|
53 | 82 | ||||||
|
Total current liabilities
|
8,121 | 9,879 | ||||||
|
Long-term debt
|
— | — | ||||||
|
Capital lease obligations, non-current
|
7 | 18 | ||||||
|
Deferred tax liabilities, non-current, net
|
1,575 | 1,516 | ||||||
|
Deferred revenue, non-current
|
222 | 261 | ||||||
|
Other non-current liabilities
|
2,083 | 2,085 | ||||||
|
Total liabilities
|
12,008 | 13,759 | ||||||
|
Commitments and Contingencies (Note 9)
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding
|
— | — | ||||||
|
Common stock, $0.001 par value; 200,000,000 shares authorized; 52,651,629 and 52,645,129 shares issued at March 31, 2012 and December 31, 2011, respectively; and 52,306,567 and 52,645,129 shares outstanding at March 31, 2012 and December 31, 2011, respectively
|
53 | 53 | ||||||
|
Additional paid-in capital
|
115,407 | 114,619 | ||||||
|
Notes receivable from stockholders
|
(24 | ) | (23 | ) | ||||
|
Accumulated other comprehensive loss
|
(50 | ) | (92 | ) | ||||
|
Treasury stock, at cost — 345,062 and 0 shares repurchased at March 31, 2012 and December 31, 2011, respectively
|
(800 | ) | — | |||||
|
Accumulated deficit
|
(22,286 | ) | (17,603 | ) | ||||
|
Total stockholders’ equity
|
92,300 | 96,954 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 104,308 | $ | 110,713 | ||||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2012
|
2011
|
||||||
|
Net revenue
|
$ | 4,756 | $ | 10,367 | ||||
|
Cost of revenue
|
3,504 | 5,703 | ||||||
|
Gross profit
|
1,252 | 4,664 | ||||||
|
Operating expenses:
|
||||||||
|
General and administrative
|
3,468 | 4,057 | ||||||
|
Sales and marketing
|
1,482 | 2,070 | ||||||
|
Research and development
|
694 | 1,029 | ||||||
|
Amortization of intangible assets
|
262 | 346 | ||||||
|
Restructuring charges
|
31 | — | ||||||
|
Total operating expenses
|
5,937 | 7,502 | ||||||
|
Loss from operations
|
(4,685 | ) | (2,838 | ) | ||||
|
Interest expense
|
(4 | ) | (20 | ) | ||||
|
Other non-operating income, net
|
72 | 194 | ||||||
|
Loss before income taxes
|
(4,617 | ) | (2,664 | ) | ||||
|
Provision for (benefit from) income taxes
|
66 | (906 | ) | |||||
|
Net loss
|
$ | (4,683 | ) | $ | (1,758 | ) | ||
|
Loss per share:
|
||||||||
|
Basic
|
$ | (0.09 | ) | $ | (0.03 | ) | ||
|
Diluted
|
$ | (0.09 | ) | $ | (0.03 | ) | ||
|
Number of shares used in per share calculations:
|
||||||||
|
Basic
|
52,618 | 52,586 | ||||||
|
Diluted
|
52,618 | 52,586 | ||||||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2012
|
2011
|
||||||
|
Net loss
|
$ | (4,683 | ) | $ | (1,758 | ) | ||
|
Other comprehensive income (loss), net of tax:
|
||||||||
|
Foreign currency translation adjustments
|
(6 | ) | (12 | ) | ||||
|
Unrealized gains on investments
|
48 | — | ||||||
|
Other comprehensive income (loss)
|
42 | (12 | ) | |||||
|
Comprehensive loss
|
$ | (4,641 | ) | $ | (1,770 | ) | ||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2012
|
2011
|
||||||
|
Cash Flows From Operating Activities
|
||||||||
|
Net loss
|
$ | (4,683 | ) | $ | (1,758 | ) | ||
|
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
||||||||
|
Depreciation and amortization
|
1,000 | 1,204 | ||||||
|
Loss on disposal of fixed assets
|
— | 77 | ||||||
|
Amortization (accretion) of premiums/discounts on investments
|
154 | — | ||||||
|
Interest accrued on notes receivables from stockholders
|
(1 | ) | — | |||||
|
Share-based compensation
|
783 | 607 | ||||||
|
Net unrealized (gain) loss on foreign currency transactions
|
(51 | ) | (188 | ) | ||||
|
Deferred income taxes
|
59 | — | ||||||
|
Provision for (recoveries of) doubtful accounts
|
31 | (10 | ) | |||||
|
Provision for warranty claims
|
(29 | ) | 77 | |||||
|
Valuation adjustments for excess or obsolete inventory
|
(18 | ) | 225 | |||||
|
Other non-cash adjustments
|
(2 | ) | (31 | ) | ||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
172 | 1,325 | ||||||
|
Unbilled receivables
|
162 | (2,651 | ) | |||||
|
Inventories
|
(508 | ) | 139 | |||||
|
Prepaid and other assets
|
570 | (164 | ) | |||||
|
Accounts payable
|
(44 | ) | (174 | ) | ||||
|
Accrued expenses and other liabilities
|
(1,945 | ) | (291 | ) | ||||
|
Income taxes payable
|
8 | 5 | ||||||
|
Deferred revenue
|
602 | (1,594 | ) | |||||
|
Net cash used in operating activities
|
(3,740 | ) | (3,202 | ) | ||||
|
Cash Flows From Investing Activities
|
||||||||
|
Capital expenditures
|
(1,014 | ) | (339 | ) | ||||
|
Proceeds from sale of capitalized assets
|
— | 55 | ||||||
|
Purchase of marketable securities
|
(861 | ) | — | |||||
|
Maturities of marketable securities
|
4,305 | — | ||||||
|
Restricted cash
|
(565 | ) | 866 | |||||
|
Net cash provided by investing activities
|
1,865 | 582 | ||||||
|
Cash Flows From Financing Activities
|
||||||||
|
Repayment of long-term debt
|
(32 | ) | (32 | ) | ||||
|
Repayment of capital lease obligation
|
(40 | ) | (115 | ) | ||||
|
Net proceeds from issuance of common stock
|
5 | 18 | ||||||
|
Repurchase of common stock
|
(800 | ) | — | |||||
|
Net cash used in financing activities
|
(867 | ) | (129 | ) | ||||
|
Effect of exchange rate differences on cash and cash equivalents
|
(3 | ) | — | |||||
|
Net decrease in cash and cash equivalents
|
(2,745 | ) | (2,749 | ) | ||||
|
Cash and cash equivalents, beginning of period
|
18,507 | 55,338 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 15,762 | $ | 52,589 | ||||
| March 31, 2012 | ||||||||||||||||
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Accumulated
Impairment
Losses
|
Net
Carrying
Amount
|
|||||||||||||
|
Developed technology
|
$ | 6,100 | $ | (1,423 | ) | $ | — | $ | 4,677 | |||||||
|
Non-compete agreements
|
1,310 | (899 | ) | — | 411 | |||||||||||
|
Backlog
|
1,300 | (1,300 | ) | — | — | |||||||||||
|
Trademarks
|
1,200 | (140 | ) | — | 1,060 | |||||||||||
|
Customer relationships
|
990 | (644 | ) | — | 346 | |||||||||||
|
Patents
|
585 | (308 | ) | (42 | ) | 235 | ||||||||||
| $ | 11,485 | $ | (4,714 | ) | $ | (42 | ) | $ | 6,729 | |||||||
|
|
December 31, 2011
|
||||||||||||||||
|
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Accumulated
Impairment
Losses
|
Net
Carrying
Amount
|
|||||||||||||
|
Developed technology
|
$ | 6,100 | $ | (1,271 | ) | $ | — | $ | 4,829 | ||||||||
|
Non-compete agreements
|
1,310 | (861 | ) | — | 449 | ||||||||||||
|
Backlog
|
1,300 | (1,300 | ) | — | — | ||||||||||||
|
Trademarks
|
1,200 | (125 | ) | — | 1,075 | ||||||||||||
|
Customer relationships
|
990 | (594 | ) | — | 396 | ||||||||||||
|
Patents
|
585 | (301 | ) | (42 | ) | 242 | |||||||||||
| $ | 11,485 | $ | (4,452 | ) | $ | (42 | ) | $ | 6,991 | ||||||||
|
Three Months Ended
March 31,
|
||||||||
|
2012
|
2011
|
|||||||
|
Numerator:
|
||||||||
|
Net loss
|
$ | (4,683 | ) | $ | (1,758 | ) | ||
|
Denominator:
|
||||||||
|
Basic weighted average common shares outstanding
|
52,618 | 52,586 | ||||||
|
Diluted weighted average common shares outstanding
|
52,618 | 52,586 | ||||||
|
Loss per share:
|
||||||||
|
Basic
|
$ | (0.09 | ) | $ | (0.03 | ) | ||
|
Diluted
|
$ | (0.09 | ) | $ | (0.03 | ) | ||
|
Three Months Ended
March 31,
|
||||||||
|
2012
|
2011
|
|||||||
|
Restricted awards*
|
8 | 37 | ||||||
|
Stock options
|
6,496 | 4,543 | ||||||
|
Warrants
|
970 | 970 | ||||||
|
March 31,
2012
|
December 31,
2011
|
|||||||
|
Contingent and other consideration for acquisition
|
$ | 3,502 | $ | 3,504 | ||||
|
Collateral for irrevocable standby letters of credit
|
7,926 | 7,326 | ||||||
|
Collateral for equipment promissory note
|
56 | 89 | ||||||
| $ | 11,484 | $ | 10,919 | |||||
|
March 31,
2012
|
December 31,
2011
|
|||||||
|
Contingent and other consideration for acquisition
|
$ | 2,502 | $ | 2,504 | ||||
|
Collateral for irrevocable standby letters of credit
|
3,603 | 3,094 | ||||||
|
Collateral for equipment promissory note
|
56 | 89 | ||||||
|
Current restricted cash
|
$ | 6,161 | $ | 5,687 | ||||
|
Contingent and other consideration for acquisition
|
$ | 1,000 | $ | 1,000 | ||||
|
Collateral for irrevocable standby letters of credit
|
4,323 | 4,232 | ||||||
|
Non-current restricted cash
|
$ | 5,323 | $ | 5,232 | ||||
| $ | 11,484 | $ | 10,919 | |||||
|
March 31,
2012
|
December 31,
2011
|
|||||||
|
Raw materials
|
$ | 4,075 | $ | 4,683 | ||||
|
Work in process
|
1,731 | 1,550 | ||||||
|
Finished goods
|
2,544 | 1,591 | ||||||
| $ | 8,350 | $ | 7,824 | |||||
|
Three Months Ended
March 31,
|
||||||||
|
|
2012
|
2011
|
||||||
|
PX
TM
devices and related products and services
|
$ | 3,078 | $ | 8,779 | ||||
|
Turbochargers and pumps
|
1,678 | 1,588 | ||||||
| $ | 4,756 | $ | 10,367 | |||||
|
Amortized
Cost
|
Gross Unrealized
Holding Gains
|
Gross Unrealized
Holding Losses
|
Fair Value
|
|||||||||||||
|
Short-term investments
|
||||||||||||||||
|
Commercial paper
|
$ | 400 | $ | — | $ | — | $ | 400 | ||||||||
|
State and local government obligations
|
2,123 | 1 | (3 | ) | 2,121 | |||||||||||
|
Corporate notes and bonds
|
10,010 | 18 | (1 | ) | 10,027 | |||||||||||
| $ | 12,533 | $ | 19 | $ | (4 | ) | $ | 12,548 | ||||||||
|
Long-term investments
|
||||||||||||||||
|
Agency obligations
|
$ | 750 | $ | — | $ | — | $ | 750 | ||||||||
|
State and local government obligations
|
1,510 | 4 | — | 1,514 | ||||||||||||
|
Corporate notes and bonds
|
4,526 | 16 | — | 4,542 | ||||||||||||
| $ | 6,786 | $ | 20 | $ | — | $ | 6,806 | |||||||||
| $ | 19,319 | $ | 39 | $ | (4 | ) | $ | 19,354 | ||||||||
|
Amortized
Cost
|
Gross Unrealized
Holding Gains
|
Gross Unrealized
Holding Losses
|
Fair
Value
|
|||||||||||||
|
Short-term investments
|
||||||||||||||||
|
Certificates of deposit
|
$ | 750 | $ | — | $ | — | $ | 750 | ||||||||
|
Commercial paper
|
1,000 | — | — | 1,000 | ||||||||||||
|
State and local government obligations
|
1,611 | — | (3 | ) | 1,608 | |||||||||||
|
Corporate notes and bonds
|
8,353 | 1 | (6 | ) | 8,348 | |||||||||||
| $ | 11,714 | $ | 1 | $ | (9 | ) | $ | 11,706 | ||||||||
|
Long-term investments
|
||||||||||||||||
|
Agency obligations
|
$ | 750 | $ | — | $ | — | $ | 750 | ||||||||
|
State and local government obligations
|
2,032 | 1 | (1 | ) | 2,032 | |||||||||||
|
Corporate notes and bonds
|
8,422 | 7 | (13 | ) | 8,416 | |||||||||||
| $ | 11,204 | $ | 8 | $ | (14 | ) | $ | 11,198 | ||||||||
| $ | 22,918 | $ | 9 | $ | (23 | ) | $ | 22,904 | ||||||||
|
March 31, 2012
|
||||||||
|
Amortized
Cost
|
Fair
Value
|
|||||||
|
Due in one year or less
|
$ | 6,190 | $ | 6,192 | ||||
|
Due after one year through three years
|
13,129 | 13,162 | ||||||
| $ | 19,319 | $ | 19,354 | |||||
|
March 31,
2012
|
||||
|
2012 (remaining 9 months)
|
$ | 44 | ||
|
2013
|
18 | |||
|
Total future minimum lease payments
|
62 | |||
|
Less: amount representing interest
|
(2 | ) | ||
|
Present value of net minimum capital lease payments
|
60 | |||
|
Less: current portion
|
(53 | ) | ||
|
Long-term portion
|
$ | 7 | ||
|
Three Months Ended
March 31,
|
||||||||
|
2012
|
2011
|
|||||||
|
Cost of revenue
|
$ | 26 | $ | 41 | ||||
|
General and administrative
|
545 | 390 | ||||||
|
Sales and marketing
|
169 | 136 | ||||||
|
Research and development
|
43 | 40 | ||||||
| $ | 783 | $ | 607 | |||||
|
March 31,
2012
|
||||
|
2012 (remaining nine months)
|
$ | 1,126 | ||
|
2013
|
1,474 | |||
|
2014
|
1,560 | |||
|
2015
|
1,477 | |||
|
2016
|
1,514 | |||
|
Thereafter
|
4,476 | |||
| $ | 11,627 | |||
|
Three Months Ended
March 31,
|
||||||||
|
2012
|
2011
|
|||||||
|
Balance, beginning of period
|
$ | 852 | $ | 1,028 | ||||
|
Warranty costs charged to cost of revenue
|
41 | 77 | ||||||
|
Utilization of warranty
|
(29 | ) | (238 | ) | ||||
|
Balance, end of period
|
$ | 864 | $ | 867 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
2012
|
2011
|
|||||||
|
Domestic revenue
|
$ | 588 | $ | 873 | ||||
|
International revenue
|
4,168 | 9,494 | ||||||
|
Total revenue
|
$ | 4,756 | $ | 10,367 | ||||
|
Revenue by country:
|
||||||||
|
UAE
|
25 | % | * | |||||
|
United States
|
12 | % | 8 | % | ||||
|
China
|
9 | % | 17 | % | ||||
|
Spain
|
8 | % | 10 | % | ||||
|
India
|
1 | % | 27 | % | ||||
|
Cyprus
|
* | 11 | % | |||||
|
Others
|
45 | % | 27 | % | ||||
|
Total
|
100 | % | 100 | % | ||||
|
|
|
Fair Value Measurement at Reporting Date Using
|
||||||||||||||
|
|
March 31,
2012
|
Quoted Prices in
Active Markets
for Identical
Assets or
Liabilities
(Level 1)
|
Significant Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale securities
|
$ | 19,354 | $ | — | $ | 19,354 | $ | — | ||||||||
|
Total
|
$ | 19,354 | $ | — | $ | 19,354 | $ | — | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Contingent consideration
|
$ | 1,524 | $ | — | $ | — | $ | 1,524 | ||||||||
|
Total
|
$ | 1,524 | $ | — | $ | — | $ | 1,524 | ||||||||
|
|
|
Fair Value Measurement at Reporting Date Using
|
||||||||||||||
|
|
December 31,
2011
|
Quoted Prices in
Active Markets
for Identical
Assets or
Liabilities
(Level 1)
|
Significant Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale securities
|
$ | 22,904 | $ | — | $ | 22,904 | $ | — | ||||||||
|
Total
|
$ | 22,904 | $ | — | $ | 22,904 | $ | — | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Contingent consideration
|
$ | 1,524 | $ | — | $ | — | $ | 1,524 | ||||||||
|
Total
|
$ | 1,524 | $ | — | $ | — | $ | 1,524 | ||||||||
|
•
|
our plan to enhance our existing energy recovery devices and to develop and manufacture new and enhanced versions of these devices;
|
|
•
|
our belief that sales of our PX-300
TM
and PX-Q300
TM
devices will represent a higher percentage of our net revenue in 2012;
|
|
•
|
our belief that the ceramics components of our PX
TM
device will result in low life-cycle maintenance costs and that our turbocharger devices have long operating lives;
|
|
•
|
our objective of finding new applications for our technology and developing new products for use outside of desalination;
|
|
•
|
our belief that our products are the most cost-effective energy recovery devices over time;
|
|
•
|
our plan to manufacture all or most of our ceramics components internally and our expectation that in-house production of ceramics will reduce production costs;
|
|
•
|
our expectation that our expenses for research and development
will increase;
|
|
•
|
our expectation that we will continue to rely on sales of our energy recovery devices for a substantial portion of our revenue;
|
|
•
|
our belief that our current facilities will be adequate through 2012;
|
|
•
|
our expectation that sales outside of the United States will remain a
significant portion of our revenue;
|
|
•
|
our expectation that future sales and marketing expense will increase as revenue increases;
|
|
•
|
our belief that our existing cash balances and cash generated from our
operations will be sufficient to meet our anticipated liquidity needs for at least the next 12 months;
|
|
•
|
our expectation that mega-project shipments will materialize in the second quarter of 2012 and continue through the balance of the year due to scheduled shipments from existing backlog and new sales opportunities; and
|
|
•
|
our expectation that, as we expand our international sales, a portion of our revenue could continue to be denominated in foreign currencies.
|
|
|
Three Months Ended March 31,
|
|||||||||||||||||||||||
|
|
2012
|
2011
|
Change
Increase / (Decrease)
|
|||||||||||||||||||||
|
Results of Operations:**
|
||||||||||||||||||||||||
|
Net revenue
|
$ | 4,756 | 100 | % | $ | 10,367 | 100 | % | $ | (5,611 | ) | (54 | )% | |||||||||||
|
Cost of revenue
|
3,504 | 74 | % | 5,703 | 55 | % | (2,199 | ) | (39 | )% | ||||||||||||||
|
Gross profit
|
1,252 | 26 | % | 4,664 | 45 | % | (3,412 | ) | (73 | )% | ||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||||||
|
General and administrative
|
3,468 | 73 | % | 4,057 | 39 | % | (589 | ) | (15 | )% | ||||||||||||||
|
Sales and marketing
|
1,482 | 31 | % | 2,070 | 20 | % | (588 | ) | (28 | )% | ||||||||||||||
|
Research and development
|
694 | 15 | % | 1,029 | 10 | % | (335 | ) | (33 | )% | ||||||||||||||
|
Amortization of intangible assets
|
262 | 6 | % | 346 | 3 | % | (84 | ) | (24 | )% | ||||||||||||||
|
Restructuring charges
|
31 | 1 | % | — | 0 | % | 31 | * | ||||||||||||||||
|
Total operating expenses
|
5,937 | 125 | % | 7,502 | 72 | % | (1,565 | ) | (21 | )% | ||||||||||||||
|
Loss from operations
|
(4,685 | ) | (99 | )% | (2,838 | ) | (27 | )% | (1,847 | ) | (65 | )% | ||||||||||||
|
Interest expense
|
(4 | ) | (0 | )% | (20 | ) | (0 | )% | (16 | ) | (80 | )% | ||||||||||||
|
Other non-operating income, net
|
72 | 2 | % | 194 | 2 | % | (122 | ) | (63 | )% | ||||||||||||||
|
Loss before income taxes
|
(4,617 | ) | (97 | )% | (2,664 | ) | (26 | )% | (1,953 | ) | (73 | )% | ||||||||||||
|
Provision for (benefit from) income taxes
|
66 | 1 | % | (906 | ) | (9 | )% | 972 | 107 | % | ||||||||||||||
|
Net loss
|
$ | (4,683 | ) | (98 | )% | $ | (1,758 | ) | (17 | )% | $ | (2,925 | ) | (166 | )% | |||||||||
|
Three Months Ended
March 31,
|
||||||||
|
|
2012
|
2011
|
||||||
|
Domestic revenue
|
12 | % | 8 | % | ||||
|
International revenue
|
88 | % | 92 | % | ||||
|
Total revenue
|
100 | % | 100 | % | ||||
|
●
|
flucuations in demand, sales cycles, and pricing levels for our products and services;
|
|
●
|
the cyclical nature of equipment purchasing for planned reverse osmosis desalination plants;
|
|
●
|
changes in customers' budgets for desalination plants and the timing of their purchasing decisions;
|
|
●
|
adverse changes in the local or global financing conditions facing our customers;
|
|
●
|
delays or postponements in the construction of desalination plants;
|
|
●
|
our ability to develop, introduce, and timely ship new products and product enhancements that meet customer demand and contractual and technical requirements, including scheduled delivery dates, performance guarantees, product certifications, and warranty terms;
|
|
●
|
the ability of our customers to obtain other critical plant components such as high-pressure pumps or membranes;
|
|
●
|
our ability to implement scalable internal systems for reporting, order processing, product delivery, purchasing, billing, and general accounting, among other functions;
|
|
●
|
our ability to maintain efficient factory throughput in our new facility and minimize overhead given significant variability in orders from quarter to quarter and year to year;
|
|
●
|
unpredictability of governmental regulations and political decision-making as to the approval or building of a desalination plant;
|
|
●
|
our ability to control costs, including our operating expenses;
|
|
●
|
our ability to purchase critical raw materials from third-party suppliers;
|
|
●
|
our ability to compete against other companies that offer energy recovery solutions;
|
|
●
|
our ability to attract and retain highly skilled employees, particularly those with relevant industry experience; and
|
|
●
|
general economic conditions in our domestic and international markets, including conditions that affect the valuation of the U.S. Dollar against other currencies.
|
|
●
|
political and economic uncertainties, which the current global economic crisis may exacerbate;
|
|
●
|
uncertainties related to the application of local contract and other laws, including reduced protection for intellectual property rights;
|
|
●
|
trade barriers and other regulatory or contractual limitations on our ability to sell and service our products in certain foreign markets;
|
|
●
|
difficulties in enforcing contracts, beginning operations as scheduled, and collecting accounts receivable, especially in emerging markets;
|
|
●
|
increased travel, infrastructure, and legal compliance costs associated with multiple international locations;
|
|
●
|
competing with non-U.S. companies not subject to the U.S. Foreign Corrupt Practices Act;
|
|
●
|
difficulty in attracting, hiring, and retaining qualified personnel; and
|
|
●
|
increasing instability in the capital markets and banking systems worldwide, especially in developing countries, which may limit project financing availability for the construction of desalination plants.
|
|
●
|
authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;
|
|
●
|
require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;
|
|
●
|
specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer, or the president;
|
|
●
|
establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;
|
|
●
|
establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered terms;
|
|
●
|
provide that our directors may be removed only for cause;
|
|
●
|
provide that vacancies on our board of directors may be filled only by a majority vote of directors then in office, even though less than a quorum;
|
|
●
|
specify that no stockholder is permitted to cumulate votes at any election of directors; and
|
|
●
|
require a super-majority of votes to amend certain of the above-mentioned provisions.
|
|
Period
|
Total
Number of
Shares
Purchased
|
Average
Price Paid
per Share
|
Total Number
of Shares
Purchased
as Part of
Publicly
Announced
Program
|
Maximum
Number of
Shares That
May Yet be
Purchased
Under the
Program
|
||||||||||||
|
January 1 – January 31, 2012
|
— | — | — | — | ||||||||||||
|
February 1 – February 29, 2012
|
— | — | — | — | ||||||||||||
|
March 1 – March 31, 2012
|
345,062 | $ | 2.28 | 345,062 | 4,654,938 | |||||||||||
|
Total
|
345,062 | $ | 2.28 | 345,062 | 4,654,938 | |||||||||||
|
Exhibit No.
|
Description
|
|
|
10.44
|
Annual Incentive Plan
|
|
|
31.1
|
Certification of Principal Executive Officer Pursuant to Exchange Act Rule 13a-14(a) or 15d—14(a), as Adopted Pursuant to Section 302 of The Sarbanes Oxley Act of 2002.
|
|
|
31.2
|
Certification of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or 15d—14(a), as Adopted Pursuant to Section 302 of The Sarbanes Oxley Act of 2002.
|
|
|
32.1
|
Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
By:
|
/s/
THOMAS S. ROONEY, JR.
Thomas S. Rooney, Jr.
|
President and Chief Executive Officer
(Principal Executive Officer)
|
May 8, 2012
|
|
/s/ ALEXANDER J. BUEHLER
Alexander J. Buehler
|
Chief Financial Officer (Principal Financial Officer)
|
May 8, 2012
|
|
|
Exhibit No.
|
Description
|
|
|
10.44
|
Annual Incentive Plan
|
|
|
31.1
|
Certification of Principal Executive Officer Pursuant to Exchange Act Rule 13a-14(a) or 15d—14(a), as Adopted Pursuant to Section 302 of The Sarbanes Oxley Act of 2002.
|
|
|
31.2
|
Certification of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or 15d—14(a), as Adopted Pursuant to Section 302 of The Sarbanes Oxley Act of 2002.
|
|
|
32.1
|
Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|